Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis — Past, Present, and Future
Jasvinder A. Singh
Topics & Concepts
Rheumatoid arthritisMedicineJanus kinaseTofacitinibImmunologyImmune systemTyrosine kinaseKinaseAutoimmune diseaseCancer researchJanus kinase inhibitorClinical trialJanus kinase 3Janus kinase 2Internal medicineBioinformaticsDiseaseArthritisImmunopathologyRheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and InteractionsChronic Lymphocytic Leukemia Research